Wednesday, May 16, 2012

Stock Alert - OraSure Technologies (OSUR) +35.3% premarket after an FDA advisory panel's recommendation - 5/16/12

OraSure Technologies (OSUR) +35.3% premarket after an FDA advisory panel's recommendation to let an HIV test be sold in retail stores; test results could be obtained in the home like tests for pregnancy and blood sugar. The panel voted in favor 17-0 twice, on potential benefits outweighing potential risks and on safety and effectiveness.
For the latest updates on the stock market, visit, 
http://daytradingstock-blog.blogspot.com/